ATE222908T1 - Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole) - Google Patents

Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole)

Info

Publication number
ATE222908T1
ATE222908T1 AT99110944T AT99110944T ATE222908T1 AT E222908 T1 ATE222908 T1 AT E222908T1 AT 99110944 T AT99110944 T AT 99110944T AT 99110944 T AT99110944 T AT 99110944T AT E222908 T1 ATE222908 T1 AT E222908T1
Authority
AT
Austria
Prior art keywords
pyrroles
pyrrolo
spiro
piperidine
Prior art date
Application number
AT99110944T
Other languages
English (en)
Inventor
Geo Adam
Frank Dautzenberg
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE222908T1 publication Critical patent/ATE222908T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT99110944T 1998-06-12 1999-06-07 Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole) ATE222908T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12
EP98124119 1998-12-18

Publications (1)

Publication Number Publication Date
ATE222908T1 true ATE222908T1 (de) 2002-09-15

Family

ID=26149342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99110944T ATE222908T1 (de) 1998-06-12 1999-06-07 Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole)

Country Status (27)

Country Link
US (1) US6075034A (de)
EP (1) EP0963987B1 (de)
JP (1) JP3308507B2 (de)
KR (1) KR100346607B1 (de)
AR (1) AR018650A1 (de)
AT (1) ATE222908T1 (de)
AU (1) AU749995B2 (de)
BR (1) BR9902245A (de)
CA (1) CA2274204C (de)
CO (1) CO5060459A1 (de)
DE (1) DE69902606T2 (de)
DK (1) DK0963987T3 (de)
ES (1) ES2181336T3 (de)
HR (1) HRP990189A2 (de)
HU (1) HUP9901909A3 (de)
ID (1) ID23283A (de)
IL (1) IL130376A0 (de)
MA (1) MA26643A1 (de)
NO (1) NO312069B1 (de)
NZ (1) NZ336186A (de)
PE (1) PE20000549A1 (de)
PL (1) PL333694A1 (de)
PT (1) PT963987E (de)
SG (1) SG76623A1 (de)
TR (1) TR199901304A3 (de)
TW (1) TW523516B (de)
YU (1) YU26599A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224038B2 (en) 2000-11-15 2006-03-09 Banyu Pharmaceutical Co., Ltd. Benzimidazole derivatives
EP1406629A1 (de) * 2001-07-02 2004-04-14 Omeros Corporation Verfahren zur induzierung von analgesie beinhaltend die verabreichung alternativ eines opiat-rezeptoragonists und eines opiat-rezeptor ähnlichen-1 rezeptoragonists und eine implantierbare infusionspumpe
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
AU2004241134A1 (en) * 2003-05-23 2004-12-02 Zealand Pharma A/S Triaza-spiro compounds as nociceptin analogues and uses thereof
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
JP4446978B2 (ja) * 2006-04-28 2010-04-07 トヨタ自動車株式会社 車両用駆動力制御装置
MX2009009355A (es) * 2007-03-01 2009-09-11 Mitsubishi Tanabe Pharma Corp Compuesto de bencimidazol y uso farmaceutico del mismo.
KR101561666B1 (ko) 2014-08-12 2015-10-20 최인석 골프 퍼팅 교정장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
AU749995B2 (en) 2002-07-04
EP0963987B1 (de) 2002-08-28
MA26643A1 (fr) 2004-12-20
NO992872L (no) 1999-12-13
HRP990189A2 (en) 2000-02-29
DK0963987T3 (da) 2002-12-30
TR199901304A2 (xx) 2000-01-21
ID23283A (id) 2000-04-05
TR199901304A3 (tr) 2000-01-21
YU26599A (sh) 2002-09-19
CO5060459A1 (es) 2001-07-30
CA2274204C (en) 2009-09-15
AU3500399A (en) 1999-12-23
BR9902245A (pt) 2000-03-21
KR100346607B1 (ko) 2002-08-07
ES2181336T3 (es) 2003-02-16
DE69902606T2 (de) 2003-04-24
KR20000006079A (ko) 2000-01-25
EP0963987A2 (de) 1999-12-15
TW523516B (en) 2003-03-11
EP0963987A3 (de) 2001-01-17
NO992872D0 (no) 1999-06-11
SG76623A1 (en) 2000-11-21
DE69902606D1 (de) 2002-10-02
HUP9901909A2 (hu) 2000-04-28
IL130376A0 (en) 2000-06-01
JP2000053680A (ja) 2000-02-22
NZ336186A (en) 2000-10-27
PL333694A1 (en) 1999-12-20
PE20000549A1 (es) 2000-07-24
AR018650A1 (es) 2001-11-28
CA2274204A1 (en) 1999-12-12
US6075034A (en) 2000-06-13
NO312069B1 (no) 2002-03-11
HU9901909D0 (en) 1999-08-30
PT963987E (pt) 2003-01-31
HUP9901909A3 (en) 2001-11-28
JP3308507B2 (ja) 2002-07-29

Similar Documents

Publication Publication Date Title
DE59409351D1 (de) Pyrrolo[3,4-c]pyrrole
HUP9900575A3 (en) Pyrazolopyrimidines as crf receptor antagonists
FI944970A7 (fi) Trisyklisiä pyrrolijohdannaisia
ATE202105T1 (de) 8-substituierte-1,3,8-triazaspiro(4,5)decan-4- onderivate
ZA976492B (en) Substituted pyrroles.
DK0837860T3 (da) Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
DE69902606D1 (de) Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole)
DK0970957T3 (da) Diaza-spiro[3.5]nonan-derivativer
ZA972829B (en) Novel pyrimido [1,2-a]indoles.
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
ZA974538B (en) Novel pyrrole derivatives.
ZA976487B (en) Substituted pyrroles.
DE59606457D1 (de) Monophasige feste Lösungen mit asymmetrischen Pyrrolo-[4,3-c]-pyrrolen als Wirten
FI943808A7 (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vast avaikuttajina
DE59510186D1 (de) Cyaniminogruppen enthaltende Pyrrolo(3,4-c)pyrrole
DE69516467D1 (de) Feste Lösungen von Pyrrolo-(3,4-c)-pyrrolen mit Chinacridonchinonen
FI952724A7 (fi) Allergian vastaisia triatsolo(pyrrolo, tieno tai furano)-atsepiinijohd annaisia
EP0424315A3 (en) Tetracyclic pyrrole lactam derivatives
DE59500031D1 (de) Aminoxidgruppen enthaltende Pyrrolo[3,4-c]pyrrole als Photorezeptoren
SI0880523T1 (sl) Pirazolopirimidini kot crf receptorski antagonisti
GB9614247D0 (en) Pyrrole derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification